Analytical Data
-
Gene name
CNN3
- Application
-
Alternative Names
Calponin, acidic isoform
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15417
-
Expression Region
2-329aa
-
Molecular Weight
40.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of CNN3 recombinant protein is rooted in the broader context of understanding the roles of coiled-coil domain-containing proteins in cellular processes. CNN3, or calcineurin homologous protein 3, is a member of the CMY family and is implicated in various biological functions, including cell cycle regulation, apoptosis, and differentiation. Research has shown that CNN3 participates in the modulation of cellular signaling pathways and can influence muscle development and heart function. Given the significance of CNN3 in both physiological and pathological contexts, including its potential associations with certain diseases such as cancer and cardiac disorders, scientists have aimed to produce recombinant forms of CNN3 to facilitate in-depth functional studies. By utilizing techniques such as molecular cloning and expression in heterologous systems, researchers can obtain large quantities of pure CNN3 protein, enabling biochemical assays, structural analyses, and exploration of its interactions with other proteins. This work not only enhances our understanding of CNN3's biological roles but also may pave the way for therapeutic applications targeting related pathways. The ongoing research into CNN3 recombinant protein signifies a crucial step in unraveling the complexities of cellular mechanisms and offers promising avenues for future medical interventions.
